FRANKLYN G. PRENDERGAST - 09 Sep 2022 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role: Director
Signature: /s/ Dietrich A. Stephan, as attorney-in-fact for Franklyn G. Prendergast
Issuer symbol: NBSE
Transactions as of: 09 Sep 2022
Net transactions value: $0
Form type: 4
Filing time: 12 Sep 2022, 17:01:33 UTC
Previous filing: 21 Jun 2022
Next filing: 12 Jun 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NBSE	Stock option (right to buy)	Award	$0	+37,600		$0.000000	37,600	09 Sep 2022	Common Stock	37,600	$0.6000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the total shares shall vest on the first anniversary of September 9, 2022, and the remaining shares shall vest on an equal monthly basis over the following 36 months.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.